tiprankstipranks
Trending News
More News >
InMed Pharmaceuticals (INM)
NASDAQ:INM
US Market
Advertisement

InMed Pharmaceuticals (INM) Income Statement

Compare
382 Followers

InMed Pharmaceuticals Income Statement

Last quarter (Q1 2026), InMed Pharmaceuticals's total revenue was $1.12M, a decrease of -11.43% from the same quarter last year. In Q1, InMed Pharmaceuticals's net income was $-1.73M. See InMed Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 4.94M$ 4.60M$ 4.14M$ 1.09M$ 0.00
Gross Profit
$ 1.71M$ 1.10M$ 1.40M$ 543.55K$ 0.00
Operating Expenses
$ 9.62M$ 9.24M$ 9.78M$ 14.34M$ 12.17M
Depreciation and Amortization
$ 534.73K$ 604.52K$ 596.00K$ 511.79K$ 149.84K
EBITDA
$ -7.26M$ -7.06M$ -7.78M$ -13.28M$ -12.17M
Operating Income
$ -7.92M$ -8.13M$ -8.38M$ -13.79M$ -12.17M
Other Income/Expenses
$ -244.14K$ 465.98K$ 444.26K$ -4.81M$ -478.14K
Pretax Income
$ -8.16M$ -7.67M$ -7.93M$ -18.60M$ -12.65M
Net Income
$ -8.16M$ -7.68M$ -7.95M$ -18.60M$ -12.65M
Per Share Metrics
Basic EPS
$ -11.44$ -27.55$ -86.00$ -21.35K$ -938.91
Diluted EPS
$ -11.44$ -27.55$ -86.00$ -21.35K$ -938.91
Weighted Average Shares Outstanding
975.99K 381.05K 122.42K 1.12K 13.44K
Weighted Average Shares Outstanding (Diluted)
975.99K 381.05K 122.42K 1.12K 13.44K
Currency in USD

InMed Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis